Status:
COMPLETED
Registry to Evaluate the ROX COUPLER in Patients With Resistant or Uncontrolled Hypertension
Lead Sponsor:
ROX Medical, Inc.
Conditions:
Hypertension
Blood Pressure, High
Eligibility:
All Genders
18-85 years
Phase:
PHASE3
Brief Summary
The purpose of this registry is to evaluate the safety and performance of the ROX COUPLER in patients with treatment-resistant or uncontrolled hypertension.
Eligibility Criteria
Inclusion
- Diagnosis of resistant or uncontrolled hypertension must be made on the basis of current findings, medical history, and physical examination.
Exclusion
- Any serious medical condition that may adversely affect the patient's safety, limit the subject's ability to participate in the registry, comply with follow-up requirements, or impact the scientific integrity of the study.
Key Trial Info
Start Date :
March 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 5 2019
Estimated Enrollment :
83 Patients enrolled
Trial Details
Trial ID
NCT01885390
Start Date
March 1 2014
End Date
May 5 2019
Last Update
May 13 2019
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
ZNA Cardio Middelheim
Antwerp, Belgium, 2020
2
St. Antonius Ziekenhuis
Nieuwegein, Netherlands, 3435CM
3
East Sussex Healthcare NHS Trust
Eastbourne, United Kingdom, BN21 2UD
4
Queen Mary University of London
London, United Kingdom, EC1M 6BQ